2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
RCOG World Congress 2025
June 23 - 25, 2025 | ExCeL London, UK
EP.1826
Gestational Diabetes Mellitus: Diagnosis, Management & Outcomes – A Study Closing the Loop (2024)
Poster Presenter
Authors
Affiliations
Part of Topic
Quality improvement
Gestational Diabetes Mellitus (GDM): Diagnosis, Management & Outcomes – A study closing the loop (2024)
Megha Batra, Oreekha Amin, Sucheta Jindal
Objectives
- To analyze data in women who have GDM
Diagnosis
Discussions
Interventions
Outcomes
140 cases in Lincoln County Hospital
72 cases in Pilgrim Hospital
- Time period of data analysis January 2023-April 2023
- Comparing current practices to previous studies (2019 and 2021) to assess progress and close the study loop
Results
- GDM prevalence across ULHT in 2019 -785 : 17.4% of total deliveries
- GDM prevalence across ULHT in 2021 – 744: 17% of total deliveries
- Prevalence of GDM during our study period, Jan –April 2023: 15% (212/1411)
- Approximately 69% of women with GDM were diagnosed between 25 and 36 weeks of gestation, while 21% were diagnosed before 25 weeks.
- Management consisted of dietary control in 55% of cases, while 45% required pharmacological treatment, including metformin and insulin.
- Compliance with NICE standards was high, with 95% of women receiving serial growth scans and the majority having documented discussions on delivery mode and timing
- Timing of delivery followed local and national guidelines, women managed on diet-only delivering by 41 weeks, on Metformin by 40 weeks, and on Insulin by 39 weeks.
- Macrosomia was reported in 9% of cases, which was lower in well-controlled GDM.- Neonatal unit (NNU) admissions showed reduced rates of 11% in GDM pregnancies.
- These findings reflect the importance of maintaining optimal glycaemic management to improve outcomes
